<p>Rejuvenate Bio is developing novel therapies to treat aging and age-related diseases through innovative targeted gene therapies and developing treatments to reverse aging and address multiple age-related diseases.</p>

Rejuvenate Bio is developing novel therapies to treat aging and age-related diseases through innovative targeted gene therapies and developing treatments to reverse aging and address multiple age-related diseases.

TechBio Founders #4: Targeting the core drivers of age-related diseases with Daniel Oliver, CEO Rejuvenate Bio

#TechBio is changing the world and the world needs to know more about it and the most disruptive companies who want to enable humanity to face up to its next challenges as a species, from fighting genetically transmitted diseases and pandemics to preventing ageing and climate change. In this podcast, we are featuring founders, investors, university professor or tech advisers sharing with us their unique view on the challenges and opportunities behind the Bioeconomy. This podcast is produced by Next Sequence, a venture capital fund focused on supporting globally the #TechBio ecosystem, from founders to investors.

Share TechBio Founders #4: Targeting the core drivers of age-related diseases with Daniel Oliver, CEO Rejuvenate Bio

Sign up to save your podcasts

TechBio Founders #4: Targeting the core drivers of age-related diseases with Daniel Oliver, CEO Rejuvenate Bio

TechBio Founders #4: Targeting the core drivers of age-related diseases with Daniel Oliver, CEO Rejuvenate Bio